Andrew Portuguese

30PUBLICATIONS
184CO-AUTHORS
Autonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 30, 2026
Early neurologic response predicts outcomes after anakinra for immune effector cell-associated neurotoxicity syndrome.

|Jul 08, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

|Jul 02, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

|Jul 01, 2026
Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

|May 20, 2026
Comparative economic analysis of B-cell maturation antigen-targeted bispecific antibodies in triple-class exposed relapsed/refractory multiple myeloma: linvoseltamab versus teclistamab and elranatamab.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

Pageof 5

Frequent Collaborators

14 joint publications

Rahul Banerjee

9 joint publications

Surbhi Sidana

9 joint publications

Emily C Liang

8 joint publications

Kelley L Julian